Key result
Late delayed PCI after STEMI is linked to ~26% more adverse events despite similar major cardiovascular events.
Why the study?
Optimal timing for delayed revascularization in hemodynamically stable STEMI patients who missed the reperfusion window remains controversial.
Does the timing of delayed stenting affect in-hospital outcomes in hemodynamically stable patients with STEMI who missed the reperfusion window?
Cohort (n=7,698)
Yes
Does the timing of delayed stenting affect in-hospital outcomes in hemodynamically stable patients with STEMI who missed the reperfusion window?
In stable STEMI patients who missed the reperfusion window, late delayed PCI (14-28 days) is associated with higher in-hospital adverse events compared to earlier delayed PCI.
Answers are grounded in this paper and cite their sources.
May warrant caution with PCI at 14-28 days post-STEMI; leaves open optimal delayed timing pending randomized trials.
Background: For hemodynamically stable patients with ST-segment elevation myocardial infarction (STEMI) who missed the reperfusion window, optimal timing for delayed revascularization remains controversial. Methods: We investigated 7,698 consecutive patients without cardiogenic shock, serious heart failure, or thrombolysis who underwent delayed stenting (12 hours to 28 days after STEMI) at multiple centers in China. The patients were divided according to delayed PCI timing into very early (12–72 hours), early (3–7 days), intermediate (7–14 days) and late (14–28 days) groups. The primary outcome was in-hospital rate of major adverse cardiovascular events (MACE); secondary outcomes were in-hospital rates of all bleeding events, heart failure and sudden cardiac arrest (SCA). All endpoint events were a composite of the primary and secondary endpoints. Results: In-hospital MACE rate was similar among groups (P=0.588). Patients who underwent late vs. very early, early and intermediate delayed PCI had higher in-hospital rates of secondary events (13% vs. 8.0%, 8.1% and 0.3%, P<0.001) and heart failure (11.8% vs. 6.2%, 6.3% and 7.6%, P<0.001, respectively). For all in-hospital events, the late vs. intermediate group was at higher risk (OR =1.26, 95% CI: 1.02 to 1.56, P=0.029); and in subgroup analysis, patients with Killip class II or III heart failure had similar rates (OR =1.02, 95% CI: 0.74 to 1.40, P=0.908); while women (OR =1.67, 95% CI: 1.07 to 2.62, P=0.024), and smokers (OR =1.46, 95% CI: 1.05 to 2.02, P=0.023) had higher rates. Conclusions: Late delayed PCI (14–28 days) after STEMI was associated with a higher incidence of in-hospital adverse events particularly in women and smokers but not with Killip class II–III heart failure, which might allow medical treatment to improve function.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2019) conducted a cohort in ST-segment elevation myocardial infarction (STEMI) (n=7,698). Late delayed PCI (14-28 days) vs. Intermediate delayed PCI (7-14 days) was evaluated on In-hospital rate of major adverse cardiovascular events (MACE) (OR 0.65, 95% CI 0.31-1.36, p=0.250). Late delayed PCI (14-28 days) after STEMI was associated with a higher incidence of overall in-hospital adverse events, although the primary endpoint of in-hospital major cardiovascular events was similar across all delayed timing groups.
Synapse has enriched 10 related papers. Consider them for comparative context: